All stock lists
Aemetis, Inc (NASDAQ:AMTX)
US · Delayed Price · Currency is USD
Basic Materials · Chemicals - Specialty
1.81+0.56 (+44.91%)
Market cap
$131M
Insider Score
Health Score
Analyst consensus
Listed since
Jun 27, 2006
Website
Insider Score
––Not scored
AMTX Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
AMTX analyst forecast
AMTX analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
AMTX 12-month price target
No published price targets in the last 12 months.
AMTX ratings mix, last 12 months
Buy Hold Sell
Best analysts covering AMTX
- Ascendiant Capital75%success rate · +4.8% avg return · 4 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AMTX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2026-08-20 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2026-05-22 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2026-04-08 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2025-11-19 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2025-10-06 |
| — | UBS | Buy | — | — | Reiterated | 2025-06-30 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2025-06-06 |
| — | UBS | Buy | — | — | Reiterated | 2025-05-09 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2025-03-17 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-12-23 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-15 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2024-09-03 |
| — | UBS | Buy | — | — | Reiterated | 2024-08-19 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-02 |
| — | Truist Securities | Hold | — | — | Reiterated | 2024-07-31 |
| — | Truist Securities | Hold | — | — | Reiterated | 2024-05-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-08 |
| — | Stifel | Buy | — | — | Reiterated | 2024-02-21 |
| — | Stifel | Buy | — | — | Reiterated | 2024-01-23 |
| — | Truist Securities | Hold | — | — | Reiterated | 2024-01-23 |
| — | Stifel | Buy | — | — | Reiterated | 2023-11-27 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-09-15 |
| — | Stifel | Buy | — | — | Reiterated | 2023-08-22 |
| — | UBS | Buy | — | — | Upgraded | 2023-08-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-08-04 |
| — | Stifel | Buy | — | — | Reiterated | 2023-07-07 |
| — | Piper Sandler | Underweight | — | — | Reiterated | 2023-06-06 |
| — | Stifel | Buy | — | — | Reiterated | 2023-04-27 |
| — | Stifel | Buy | — | — | Reiterated | 2023-04-14 |
| — | Truist Securities | Hold | — | — | Reiterated | 2023-04-13 |
| — | Truist Securities | Hold | — | — | Reiterated | 2023-02-01 |
| — | Truist Securities | Hold | — | — | Downgraded | 2022-08-09 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2022-06-13 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2021-08-23 |
AMTX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-12 | -0.27 | -0.08 | $59.3M | $53.7M |
| 2026-05-07 | -0.27 | -0.33 | $66.7M | $54.6M |
| 2026-08-06 | -0.29 | -0.13 | $67.7M | $62.7M |
| 2026-11-05 | -0.20 | -0.02 | $74.2M | $88.2M |
| 2027-03-11Upcoming | -0.23 | — | $72.9M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.